These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 11875044)

  • 1. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy.
    Pujol A; Hindelang C; Callizot N; Bartsch U; Schachner M; Mandel JL
    Hum Mol Genet; 2002 Mar; 11(5):499-505. PubMed ID: 11875044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency.
    Dumser M; Bauer J; Lassmann H; Berger J; Forss-Petter S
    Acta Neuropathol; 2007 Dec; 114(6):573-86. PubMed ID: 17828604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
    Singh J; Olle B; Suhail H; Felicella MM; Giri S
    J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy.
    Pujol A; Ferrer I; Camps C; Metzger E; Hindelang C; Callizot N; Ruiz M; Pàmpols T; Giròs M; Mandel JL
    Hum Mol Genet; 2004 Dec; 13(23):2997-3006. PubMed ID: 15489218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders.
    Corzo D; Gibson W; Johnson K; Mitchell G; LePage G; Cox GF; Casey R; Zeiss C; Tyson H; Cutting GR; Raymond GV; Smith KD; Watkins PA; Moser AB; Moser HW; Steinberg SJ
    Am J Hum Genet; 2002 Jun; 70(6):1520-31. PubMed ID: 11992258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy.
    Schlüter A; Espinosa L; Fourcade S; Galino J; López E; Ilieva E; Morató L; Asheuer M; Cook T; McLaren A; Reid J; Kelly F; Bates S; Aubourg P; Galea E; Pujol A
    Hum Mol Genet; 2012 Mar; 21(5):1062-77. PubMed ID: 22095690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Brain Delivery of Dendrimer-4-Phenylbutyrate Ameliorates Neurological Deficits in a Long-Term ABCD1-Deficient Mouse Model of X-Linked Adrenoleukodystrophy.
    Nemeth CL; Gӧk Ö; Tomlinson SN; Sharma A; Moser AB; Kannan S; Kannan RM; Fatemi A
    Neurotherapeutics; 2023 Jan; 20(1):272-283. PubMed ID: 36207570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy.
    Martinović K; Bauer J; Kunze M; Berger J; Forss-Petter S
    Acta Neuropathol Commun; 2023 Jun; 11(1):98. PubMed ID: 37331971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients.
    Jang J; Kang HC; Kim HS; Kim JY; Huh YJ; Kim DS; Yoo JE; Lee JA; Lim B; Lee J; Yoon TM; Park IH; Hwang DY; Daley GQ; Kim DW
    Ann Neurol; 2011 Sep; 70(3):402-9. PubMed ID: 21721033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of deuterium-stabilized (R)-pioglitazone-PXL065-for X-linked adrenoleukodystrophy.
    Monternier PA; Singh J; Parasar P; Theurey P; DeWitt S; Jacques V; Klett E; Kaur N; Nagaraja TN; Moller DE; Hallakou-Bozec S
    J Inherit Metab Dis; 2022 Jul; 45(4):832-847. PubMed ID: 35510808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy.
    Asheuer M; Bieche I; Laurendeau I; Moser A; Hainque B; Vidaud M; Aubourg P
    Hum Mol Genet; 2005 May; 14(10):1293-303. PubMed ID: 15800013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy.
    López-Erauskin J; Galino J; Ruiz M; Cuezva JM; Fabregat I; Cacabelos D; Boada J; Martínez J; Ferrer I; Pamplona R; Villarroya F; Portero-Otín M; Fourcade S; Pujol A
    Hum Mol Genet; 2013 Aug; 22(16):3296-305. PubMed ID: 23604518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.
    Fourcade S; López-Erauskin J; Galino J; Duval C; Naudi A; Jove M; Kemp S; Villarroya F; Ferrer I; Pamplona R; Portero-Otin M; Pujol A
    Hum Mol Genet; 2008 Jun; 17(12):1762-73. PubMed ID: 18344354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked adrenomyeloneuropathy associated with 14 novel ALD-gene mutations: no correlation between type of mutation and age of onset.
    Wichers M; Köhler W; Brennemann W; Boese V; Sokolowski P; Bidlingmaier F; Ludwig M
    Hum Genet; 1999; 105(1-2):116-9. PubMed ID: 10480364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage.
    Ferrer I; Kapfhammer JP; Hindelang C; Kemp S; Troffer-Charlier N; Broccoli V; Callyzot N; Mooyer P; Selhorst J; Vreken P; Wanders RJ; Mandel JL; Pujol A
    Hum Mol Genet; 2005 Dec; 14(23):3565-77. PubMed ID: 16223892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight novel mutations in the ABCD1 gene and clinical characteristics of 25 Chinese patients with X-linked adrenoleukodystrophy.
    Chu SS; Ye J; Zhang HW; Han LS; Qiu WJ; Gao XL; Gu XF
    World J Pediatr; 2015 Nov; 11(4):366-73. PubMed ID: 26454440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations.
    Kemp S; Pujol A; Waterham HR; van Geel BM; Boehm CD; Raymond GV; Cutting GR; Wanders RJ; Moser HW
    Hum Mutat; 2001 Dec; 18(6):499-515. PubMed ID: 11748843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis.
    Singh I; Pujol A
    Brain Pathol; 2010 Jul; 20(4):838-44. PubMed ID: 20626745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of X-linked adrenoleukodystrophy.
    Berger J; Forss-Petter S; Eichler FS
    Biochimie; 2014 Mar; 98(100):135-42. PubMed ID: 24316281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCD1 mutations and phenotype distribution in Chinese patients with X-linked adrenoleukodystrophy.
    Niu YF; Ni W; Wu ZY
    Gene; 2013 Jun; 522(1):117-20. PubMed ID: 23566833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.